Autologous tumoral and PD-L1-carried exosomes contribute to immunosuppression and impede anti-PD-1 therapy [65] via inducing tumour-specific CD8 + T cell exhaustion [66] and suppression [67] and thus reducing immune infiltration. This evidence concerns the gene CD274 and neoplasm.